ProCE Banner Activity

Leveraging Predictive Biomarkers for Targeted Therapies in NSCLC

Slideset Download
Download these expert-selected slides to learn strategies in using biomarkers to guide treatment decisions for your patients with NSCLC.

Released: April 27, 2021

Expiration: April 26, 2022

No longer available for credit.

Share

Faculty

Matthew Gubens

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Janssen administered by Scientific Affairs

Faculty Disclosure

Primary Author

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Matthew Gubens, MD, MS, has disclosed that he has received consulting fees from AstraZeneca, BeyondSpring, Bristol-Myers Squibb, Inivata, and Sanofi, and funds for research support from Amgen, Celgene, Johnson & Johnson, Merck, Novartis, OncoMed, Roche, and Trizell.